Literature DB >> 27634369

Current challenges and future directions for liver transplantation.

Pierluigi Toniutto1, Alberto Zanetto2, Alberto Ferrarese2, Patrizia Burra2.   

Abstract

Liver transplantation is an effective and widely used therapy for several patients with acute and chronic liver diseases. The discrepancy between the number of patients on the waiting list and available donors remains the key issue and is responsible for the high rate of waiting list mortality. The recent news is that the majority of patients with hepatitis C virus related liver disease will be cured by new antivirals therefore we should expect soon a reduction in the need of liver transplantation for these recipients. This review aims to highlight, in two different sections, the main open issues of liver transplantation concerning the current and future strategies to the best use of limited number of organs. The first section cover the strategies to increase the donor pool, discussing the use of older donors, split grafts, living donation and donation after cardiac death and mechanical perfusion systems to improve the preservation of organs before liver transplantation. Challenges in immunosuppressive therapy and operational tolerance induction will be evaluated as potential tools to increase the survival in liver transplant recipients and to reducing the need of re-transplantation. The second section is devoted to the evaluation of possible new indications to liver transplantation, where the availability of organs by implementing the strategies mentioned in the first section and the reduction in the number of waiting transplants for HCV disease is realized. Among these new potential indications for transplantation, the expansion of the Milan criteria for hepatocellular cancer is certainly the most open to question.
© 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  hepatocellular carcinoma; liver transplantation; machine perfusion; steatosis

Mesh:

Substances:

Year:  2016        PMID: 27634369     DOI: 10.1111/liv.13255

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  15 in total

1.  Evaluation of Apelin/APJ system expression in hepatocellular carcinoma as a function of clinical severity.

Authors:  Manuela Cabiati; Melania Gaggini; Paolo De Simone; Silvia Del Ry
Journal:  Clin Exp Med       Date:  2020-11-17       Impact factor: 3.984

Review 2.  Recent advances in understanding and managing liver transplantation.

Authors:  Francesco Paolo Russo; Alberto Ferrarese; Alberto Zanetto
Journal:  F1000Res       Date:  2016-12-21

3.  Transplantation of human matrix metalloproteinase-1 gene-modified bone marrow-derived mesenchymal stem cell attenuates CCL4-induced liver fibrosis in rats.

Authors:  Chao Du; Mingde Jiang; Xiaolong Wei; Jianpin Qin; Hui Xu; Yunxia Wang; Yong Zhang; Dejiang Zhou; Hongli Xue; Shumei Zheng; Weizheng Zeng
Journal:  Int J Mol Med       Date:  2018-02-27       Impact factor: 4.101

Review 4.  Cell-Based Therapies for Tissue Fibrosis.

Authors:  Rebecca Lim; Sharon D Ricardo; William Sievert
Journal:  Front Pharmacol       Date:  2017-09-22       Impact factor: 5.810

Review 5.  Impact of Melatonin in Solid Organ Transplantation-Is It Time for Clinical Trials? A Comprehensive Review.

Authors:  Philipp Stiegler; Augustinas Bausys; Bettina Leber; Kestutis Strupas; Peter Schemmer
Journal:  Int J Mol Sci       Date:  2018-11-08       Impact factor: 5.923

Review 6.  Relaxin Positively Influences Ischemia-Reperfusion Injury in Solid Organ Transplantation: A Comprehensive Review.

Authors:  Lina Jakubauskiene; Matas Jakubauskas; Bettina Leber; Kestutis Strupas; Philipp Stiegler; Peter Schemmer
Journal:  Int J Mol Sci       Date:  2020-01-17       Impact factor: 5.923

Review 7.  New Perspectives in Liver Transplantation: From Regeneration to Bioengineering.

Authors:  Debora Bizzaro; Francesco Paolo Russo; Patrizia Burra
Journal:  Bioengineering (Basel)       Date:  2019-09-11

Review 8.  Bioengineering considerations in liver regenerative medicine.

Authors:  Ogechi Ogoke; Janet Oluwole; Natesh Parashurama
Journal:  J Biol Eng       Date:  2017-11-26       Impact factor: 4.355

Review 9.  Evolving Cell-Based and Cell-Free Clinical Strategies for Treating Severe Human Liver Diseases.

Authors:  Viviana Cernigliaro; Rossella Peluso; Beatrice Zedda; Lorenzo Silengo; Emanuela Tolosano; Rinaldo Pellicano; Fiorella Altruda; Sharmila Fagoonee
Journal:  Cells       Date:  2020-02-07       Impact factor: 6.600

10.  Functional Microbiomics Reveals Alterations of the Gut Microbiome and Host Co-Metabolism in Patients With Alcoholic Hepatitis.

Authors:  Bei Gao; Yi Duan; Sonja Lang; Dinesh Barupal; Tsung-Chin Wu; Luis Valdiviez; Bryan Roberts; Ying Yng Choy; Tong Shen; Gregory Byram; Ying Zhang; Sili Fan; Benjamin Wancewicz; Yan Shao; Kevin Vervier; Yanhan Wang; Rongrong Zhou; Lu Jiang; Shilpa Nath; Rohit Loomba; Juan G Abraldes; Ramon Bataller; Xin M Tu; Peter Stärkel; Trevor D Lawley; Oliver Fiehn; Bernd Schnabl
Journal:  Hepatol Commun       Date:  2020-06-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.